Can post-treatment free PSA ratio be used to predict adverse outcomes in recurrent prostate cancer?
Goldberg H, Glicksman R, Woon D, Hoffman A, Shaikh H, Chandrasekar T, Klaassen Z, Wallis CJD, Ahmad AE, Sanmamed-Salgado N, Qu X, Moraes FY, Diamandis EP, Berlin A, Fleshner NE.
Goldberg H, et al. Among authors: moraes fy.
BJU Int. 2021 Jun;127(6):654-664. doi: 10.1111/bju.15236. Epub 2020 Sep 26.
BJU Int. 2021.
PMID: 32926761